The influence of age and Rhodococcus equi infection on CD1 expression by equine antigen presenting cells

Veterinary Immunology and Immunopathology

Volumn 130, Issue 3-4, 2009, Pages 197-209

  Pargass, Indira S ^a   Wills, Tamara B ^a   Davis, William C ^a   Wardrop, K Jane ^a   Alperin, Debby C ^a   Hines, Stephen A ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

APC; CD1; Equine; Lipid antigen; MHC unrestricted; Rhodococcus

Indexed keywords

CD1 ANTIGEN; CD1B ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD1; UNCLASSIFIED DRUG;

ACTINOMYCOSIS; AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; CROSS REACTION; DOWN REGULATION; HORSE DISEASE; HOST PATHOGEN INTERACTION; INFECTION SENSITIVITY; LUNG ALVEOLUS MACROPHAGE; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; RHODOCOCCUS EQUI; UPREGULATION;

ACTINOMYCETALES INFECTIONS; AGING; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD1; CROSS REACTIONS; HORSE DISEASES; HORSES; HUMANS; MACROPHAGES; MODELS, IMMUNOLOGICAL; PNEUMONIA, BACTERIAL; RHODOCOCCUS EQUI;

BACTERIA (MICROORGANISMS); EQUIDAE; MYCOBACTERIUM TUBERCULOSIS; RHODOCOCCUS; RHODOCOCCUS EQUI;

EID: 67649659900     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.02.007     Document Type: Article

References (46)

1. Amprey J., Späth G., and Porcelli S. Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani. Infect. Immun. 72 (2004) 589-592
2. Barral D., and Brenner M. CD1 antigen presentation: how it works. Nat. Rev. Immunol. 7 (2007) 929-941
3. Breathnach C., Sturgill-Wright T., Stiltner J., Adams A., Lunn D., and Horohov D. Foals are interferon gamma-deficient at birth. Vet. Immunol. Immunopathol. 112 (2006) 199-209
4. Bricard G., and Porcelli S. Antigen presentation by CD1 molecules and the generation of lipid-specific T cell immunity. Cell. Mol. Life Sci. 64 (2007) 1824-1840
5. Brigl M., and Brenner M. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22 (2004) 817-890
6. Canaday D., Chakravarti S., Srivastava T., Tisch D., Cheruvu V., Smialek J., Harding C., and Ramachandra L. Class II MHC antigen presentation defect in neonatal monocytes is not correlated with decreased MHC-II expression. Cell. Immunol. 243 (2006) 96-106
7. Chaffin M., Cohen N., Martens R., Edwards R., Nevill M., and Smith R.R. Hematologic and immunophenotypic factors associated with development of Rhodococcus equi pneumonia of foals at equine breeding farms with endemic infection. Vet. Immunol. Immunopathol. 100 (2004) 33-48
8. Dascher C., Hiromatsu K., Xiong X., Morehouse C., Watts G., Liu G., McMurray D., LeClair K., Porcelli S., and Brenner M. Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis. Int. Immunol. 15 (2003) 915-925
9. De Libero G., and Mori L. How T cells get grip on lipid antigens. Curr. Opin. Immunol. 20 (2008) 96-104
10. Flaminio M., Borges A., Nydam D., Horohov D., Hecker R., and Matychak M. The effect of CpG-ODN on antigen presenting cells of the foal. J. Immune Based Ther. Vaccines 5 (2007) 1-17
11. Flores-Batista V., Boechat N., Lago P., Lazzarini L., Pessanha L., Almeida A., Mafort T., Kritski A., Ho J., and Lapa-E-Silva J. Low expression of antigen-presenting and costimulatory molecules by lung cells from tuberculosis patients. Braz. J. Med. Biol. Res. 40 (2007) 1671-1679
12. Flynn J., and Ernst J. Immune responses in tuberculosis. Curr. Opin. Immunol. 12 (2000) 432-436
13. Giuliani A., Prete S., Graziani G., Aquino A., Balduzzi A., Sugita M., Brenner M., Iona E., Fattorini L., Orefici G., Porcelli S., and Bonmassar E. Influence of Mycobacterium bovis bacillus Calmette Guérin on in vitro induction of CD1 molecules in human adherent mononuclear cells. Infect. Immun. 69 (2001) 7461-7470
14. Gumperz J. The ins and outs of CD1 molecules: bringing lipids under immunological surveillance. Traffic 7 (2006) 2-13
15. Hines M., Paasch K., Alperin D., Palmer G., Westhoff N., and Hines S. Immunity to Rhodococcus equi: antigen-specific recall responses in the lungs of adult horses. Vet. Immunol. Immunopathol. 79 (2001) 101-114
16. Hines S., Kanaly S., Byrne B., and Palmer G. Immunity to Rhodococcus equi. Vet. Microbiol. 56 (1997) 177-185
17. Hines S., Stone D., Hines M., Alperin D., Knowles D., Norton L., Hamilton M., Davis W., and McGuire T. Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4+ and CD8+ T lymphocytes. Clin. Diagn. Lab. Immunol. 10 (2003) 208-215
18. Hiromatsu K., Dascher C., Sugita M., Gingrich-Baker C., Behar S., LeClair K., Brenner M., and Porcelli S. Characterization of guinea-pig group 1 CD1 proteins. Immunology 106 (2002) 159-172
19. Hondalus M. Pathogenesis and virulence of Rhodococcus equi. Vet. Microbiol. 56 (1997) 257-268
20. Jacks S., Giguère S., Crawford P., and Castleman W. Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction. Clin. Vaccine Immunol. 14 (2007) 669-677
21. Kanaly S., Hines S., and Palmer G. Failure of pulmonary clearance of Rhodococcus equi infection in CD4+ T-lymphocyte-deficient transgenic mice. Infect. Immun. 61 (1993) 4929-4932
22. Kanaly S., Hines S., and Palmer G. Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infect. Immun. 63 (1995) 3037-3041
23. Kanaly S., Hines S., and Palmer G. Transfer of a CD4+ Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung. Infect. Immun. 64 (1996) 1126-1132
24. Kasinrerk W., Baumruker T., Majdic O., Knapp W., and Stockinger H. CD1 molecule expression on human monocytes induced by granulocyte-macrophage colony-stimulating factor. J. Immunol. 150 (1993) 579-584
25. Kohler A., Stone D., Hines M., Byrne B., Alperin D., Norton L., and Hines S. Rhodococcus equi secreted antigens are immunogenic and stimulate a type 1 recall response in the lungs of horses immune to R. equi infection. Infect. Immun. 71 (2003) 6329-6337
26. Lopez A., Hines M., Palmer G., Alperin D., and Hines S. Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi. Clin. Diagn. Lab. Immunol. 9 (2002) 1270-1276
27. Meijer W., and Prescott J. Rhodococcus equi. Vet. Res. 35 (2004) 383-396
28. Muscatello G., Leadon D., Klayt M., Ocampo-Sosa A., Lewis D., Fogarty U., Buckley T., Gilkerson J., Meijer W., and Vazquez-Boland J. Rhodococcus equi infection in foals: the science of 'rattles'. Equine Vet. J. 39 (2007) 470-478
29. Park S., and Bendelac A. CD1-restricted T-cell responses and microbial infection. Nature 406 (2000) 788-792
30. Patton K., McGuire T., Fraser D., and Hines S. Rhodococcus equi-infected macrophages are recognized and killed by CD8+ T lymphocytes in a major histocompatibility complex class I-unrestricted fashion. Infect. Immun. 72 (2004) 7073-7083
31. Patton K., McGuire T., Hines M., Mealey R., and Hines S. Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals. Infect. Immun. 73 (2005) 2083-2093
32. Porcelli S., and Modlin R. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17 (1999) 297-329
33. Raabe M.R., Issel C.J., and Montelaro R.C. Equine monocyte-derived macrophage cultures and their applications for infectivity and neutralization studies of equine infectious anemia virus. J. Virol. Methods 71 (1998) 87-104
34. Scanga C., Mohan V., Yu K., Joseph H., Tanaka K., Chan J., and Flynn J. Depletion of CD4 (+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J. Exp. Med. 192 (2000) 347-358
35. Schaible U., and Kaufmann S. CD1 and CD1-restricted T cells in infections with intracellular bacteria. Trends Microbiol. 8 (2000) 419-425
36. Shams H., Wizel B., Weis S., Samten B., and Barnes P. Contribution of CD8 (+) T cells to gamma interferon production in human tuberculosis. Infect. Immun. 69 (2001) 3497-3501
37. Shinkai K., and Locksley R. CD1, tuberculosis, and the evolution of major histocompatibility complex molecules. J. Exp. Med. 191 (2000) 907-914
38. Steinbach F., Stark R., Ibrahim S., Gawad E., Ludwig H., Walter J., Commandeur U., and Mauel S. Molecular cloning and characterization of markers and cytokines for equid myeloid cells. Vet. Immunol. Immunopathol. 108 (2005) 227-236
39. Stenger S., Niazi K., and Modlin R. Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J. Immunol. 161 (1998) 3582-3588
40. Sugita M., Cernadas M., and Brenner M. New insights into pathways for CD1-mediated antigen presentation. Curr. Opin. Immunol. 16 (2004) 90-95
41. Sullivan B., Nagarajan N., and Kronenberg M. CD1 and MHC II find different means to the same end. Trends Immunol. 26 (2005) 282-288
42. Ulanova M., Tarkowski A., Porcelli S., and Hanson L. Antigen-specific regulation of CD1 expression in humans. J. Clin. Immunol. 20 (2000) 203-211
43. Ulrichs T., Moody D., Grant E., Kaufmann S., and Porcelli S. T-cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection. Infect. Immun. 71 (2003) 3076-3087
44. Van Kaer L., and Joyce S. Viral evasion of antigen presentation: not just for peptides anymore. Nat. Immunol. 7 (2006) 795-797
45. Weinstock D., and Brown A. Rhodococcus equi: an emerging pathogen. Clin. Infect. Dis. 34 (2002) 1379-1385
46. Young D., and Moody D. T-cell recognition of glycolipids presented by CD1 proteins. Glycobiology 16 (2006) 103R-112R